TipRanks
Geratherm Medical AG (DE:GME)
XETRA:GME
Want to see DE:GME full AI Analyst Report?

Geratherm Medical (GME) Stock Statistics & Valuation Metrics

10 Followers

Total Valuation

Geratherm Medical has a market cap or net worth of €12.03M. The enterprise value is €7.55.
Market Cap€12.03M
Enterprise Value€7.55

Share Statistics

Geratherm Medical has 5,444,998 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,444,998
Owned by Insiders―
Owned by Institutions―

Financial Efficiency

Geratherm Medical’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -4.79%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-4.79%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee98.44K
Profits Per Employee-5.42K
Employee Count151
Asset Turnover0.57
Inventory Turnover3.44

Valuation Ratios

The current PE Ratio of Geratherm Medical is ―. Geratherm Medical’s PEG ratio is 0.09.
PE Ratio―
PS Ratio1.05
PB Ratio0.80
Price to Fair Value0.80
Price to FCF12.78
Price to Operating Cash Flow21.49
PEG Ratio0.09

Income Statement

In the last 12 months, Geratherm Medical had revenue of 14.86M and earned -818.99K in profits. Earnings per share was -0.15.
Revenue14.86M
Gross Profit2.37M
Operating Income-1.31M
Pretax Income-906.97K
Net Income-818.99K
EBITDA-154.63K
Earnings Per Share (EPS)-0.15

Cash Flow

In the last 12 months, operating cash flow was 618.00K and capital expenditures -199.00K, giving a free cash flow of 419.00K billion.
Operating Cash Flow618.00K
Free Cash Flow419.00K
Free Cash Flow per Share0.08

Dividends & Yields

Geratherm Medical pays an annual dividend of €0.1, resulting in a dividend yield of 4.61%
Dividend Per Share€0.1
Dividend Yield4.61%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―

Stock Price Statistics

Beta0.59
52-Week Price Change-60.19%
50-Day Moving Average2.51
200-Day Moving Average2.63
Relative Strength Index (RSI)28.21
Average Volume (3m)295.00

Important Dates

Geratherm Medical upcoming earnings date is Apr 27, 2027, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateApr 27, 2027
Ex-Dividend Date―

Financial Position

Geratherm Medical as a current ratio of 6.41, with Debt / Equity ratio of 11.31%
Current Ratio6.41
Quick Ratio4.99
Debt to Market Cap0.26
Net Debt to EBITDA33.19
Interest Coverage Ratio-16.89

Taxes

In the past 12 months, Geratherm Medical has paid -78.58K in taxes.
Income Tax-78.58K
Effective Tax Rate0.09

Enterprise Valuation

Geratherm Medical EV to EBITDA ratio is -67.97, with an EV/FCF ratio of 8.59.
EV to Sales0.71
EV to EBITDA-67.97
EV to Free Cash Flow8.59
EV to Operating Cash Flow7.58

Balance Sheet

Geratherm Medical has €8.81M in cash and marketable securities with €2.19M in debt, giving a net cash position of €6.62M billion.
Cash & Marketable Securities€8.81M
Total Debt€2.19M
Net Cash€6.62M
Net Cash Per Share€1.22
Tangible Book Value Per Share€3.27

Margins

Gross margin is 66.77%, with operating margin of -8.84%, and net profit margin of -5.51%.
Gross Margin66.77%
Operating Margin-8.84%
Pretax Margin-6.10%
Net Profit Margin-5.51%
EBITDA Margin-1.04%
EBIT Margin-8.84%

Analyst Forecast

The average price target for Geratherm Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast1.58%
EPS Growth Forecast-148.73%

Scores

Smart Score5
AI Score―